Table 7.
Parameter (Units) | Placebo (n = 20) | LI10903F (n = 20) | Pvalue |
---|---|---|---|
Liver Function | |||
SGOT (U/L) |
−1.50 ± 3.63 |
−2.55 ± 6.36 |
0.397 |
SGPT (U/L) |
−7.65 ± 2.65 |
−11.70 ± 4.65 |
0.839 |
Cardiac Function | |||
Systolic BP (mm Hg) |
−2.40 ± 3.00 |
−12.53 ± 3.92 |
0.105 |
Diastolic BP (mm Hg) |
−0.70 ± 2.07 |
−5.05 ± 2.89 |
0.975 |
Pulse rate (beats/min) |
0.80 ± 1.48 |
−0.11 ± 1.06 |
0.786 |
Metabolic panel | |||
Cholesterol (mg/dL) |
12.20 ± 7.47 |
−1.2 ± 6.83 |
0.119 |
Triglycerides (mg/dL) |
−8.76 ± 17.32 |
−26.50 ± 30.27 |
0.041* |
LDL (mg/dL) |
−23.43 ± 7.08 |
−11.64 ± 13.37 |
0.155 |
HDL (mg/dL) |
−3.04 ± 1.23 |
1.33 ± 4.44 |
0.873 |
Fasting Glucose (mg/dL) | −6.20 ± 10.68 | −16.15 ± 7.35 | 0.445 |
Results are presented as Mean ± SEM. *Statistical significant difference is between the placebo and the herbal groups.
Abbreviations: SGOT=Serum glutamic oxaloacetic transaminase; SGPT=Serum glutamic pyruvic transaminase; LDL=Low density lipoproteins; HDL=High density lipoproteins.